Paper39802400
Valosin-containing protein (VCP), a component of tumor-derived extracellular vesicles, impairs the barrier integrity of brain microvascular endothelial cells.
Teles RHG and 9 others. BBA Adv, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Valosin-containing protein (VCP), a component of tumor-derived extracellular vesicles, impairs the barrier integrity of brain microvascular endothelial cells. Papers, record 39802400. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39802400
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Valosin-containing protein (VCP), a component of tumor-derived extracellular vesicles, impairs the barrier integrity of brain microvascular endothelial cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30617994 | Hypoxia-Induced MicroRNA-212/132 Alter Blood-Brain Barrier Integrity Through Inhibition of Tight Junction-Associated Proteins in Human and Mouse Brain Microvascular Endothelial Cells. | Transl Stroke Res | 2019 | https://conductscience.org/library/papers/30617994 | PubMed |
| 2 | 30654824 | Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP). | Breast Cancer Res | 2019 | https://conductscience.org/library/papers/30654824 | PubMed |
| 3 | 32145571 | Clinical outcome of patients with brain metastases from breast cancer - A population based study over 21 years. | Breast | 2020 | https://conductscience.org/library/papers/32145571 | PubMed |
| 4 | 27010333 | UniProt Tools. | Curr Protoc Bioinformatics | 2016 | https://conductscience.org/library/papers/27010333 | PubMed |
| 5 | 34322205 | Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin. | J Extracell Vesicles | 2021 | https://conductscience.org/library/papers/34322205 | PubMed |
| 6 | 29622464 | A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29622464 | PubMed |
| 7 | 18258663 | Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. | J Physiol | 2008 | https://conductscience.org/library/papers/18258663 | PubMed |
| 8 | 34485835 | The role of extracellular vesicles in the physiological and pathological regulation of the blood-brain barrier. | FASEB Bioadv | 2021 | https://conductscience.org/library/papers/34485835 | PubMed |
| 9 | 30833190 | OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling. | EBioMedicine | 2019 | https://conductscience.org/library/papers/30833190 | PubMed |
| 10 | 29248546 | Accelerated Endothelial to Mesenchymal Transition Increased Fibrosis via Deleting Notch Signaling in Wound Vasculature. | J Invest Dermatol | 2018 | https://conductscience.org/library/papers/29248546 | PubMed |
| 11 | 30867590 | Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups. | Nature | 2019 | https://conductscience.org/library/papers/30867590 | PubMed |
| 12 | 25106661 | Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis. | Breast Cancer Res Treat | 2014 | https://conductscience.org/library/papers/25106661 | PubMed |
| 13 | 25613900 | Proteomics. Tissue-based map of the human proteome. | Science | 2015 | https://conductscience.org/library/papers/25613900 | PubMed |
| 14 | 24009886 | Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. | J Extracell Vesicles | 2012 | https://conductscience.org/library/papers/24009886 | PubMed |
| 15 | 37749707 | Inflammasome activation in peritumoral astrocytes is a key player in breast cancer brain metastasis development. | Acta Neuropathol Commun | 2023 | https://conductscience.org/library/papers/37749707 | PubMed |
| 16 | 31479239 | Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier via Transcytosis. | ACS Nano | 2019 | https://conductscience.org/library/papers/31479239 | PubMed |
| 17 | 33239692 | VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots. | Sci Rep | 2020 | https://conductscience.org/library/papers/33239692 | PubMed |
| 18 | 17483330 | Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. | Cancer Res | 2007 | https://conductscience.org/library/papers/17483330 | PubMed |
| 19 | 36291916 | Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36291916 | PubMed |
| 20 | 32521270 | Phospho-Ser784-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer. | Cell Rep | 2020 | https://conductscience.org/library/papers/32521270 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953413 | The Current Landscape of Exosome-Based Strategies for Breast Cancer Brain Metastasis: From Mechanistic Insights to Therapeutic Potential. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42953413 | PubMed |
| 42042628 | The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells. | NeuroSci | 2026 | https://conductscience.org/library/papers/42042628 | PubMed |
| 41574208 | Anti-HER2-targeted therapies: effects on human in vitro blood-brain barrier models. | Front Drug Deliv | 2025 | https://conductscience.org/library/papers/41574208 | PubMed |
| 41488927 | The ion transport, GPCR, and RTK toolkit expression in the human cerebrovascular endothelial cell line, hCMEC/D3: an Omics perspective. | Front Physiol | 2025 | https://conductscience.org/library/papers/41488927 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FLT1 | 2321 | PubTator's text mining | https://conductscience.org/library/genes/2321 | NCBI Gene |
| KDR | 3791 | PubTator's text mining | https://conductscience.org/library/genes/3791 | NCBI Gene |
| VCP | 7415 | PubTator's text mining | https://conductscience.org/library/genes/7415 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39802400
GET https://conductscience.org/api/papers/v1/39802400/references?page=2